| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/15/1998 | US5807698 Human cyclin E |
| 09/15/1998 | US5807557 Vaccine |
| 09/14/1998 | CA2231917A1 Promoter of the cdc25b gene, its preparation and use |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/13/1998 | CA2229515A1 Expression of a foamy virus envelope protein |
| 09/13/1998 | CA2199989A1 Expression of a foamy virus envelope protein |
| 09/11/1998 | WO1998039659A1 Screening and treatment using complement regulator or receptor proteins |
| 09/11/1998 | WO1998039467A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 09/11/1998 | WO1998039466A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 09/11/1998 | WO1998039465A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 09/11/1998 | WO1998039464A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 09/11/1998 | WO1998039463A2 Lentivirus based vector and vector system |
| 09/11/1998 | WO1998039449A1 COMPOSITIONS AND USE OF M-CSF-alpha |
| 09/11/1998 | WO1998039439A1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 09/11/1998 | WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/11/1998 | WO1998039434A1 Methods and reagents for modulating apoptosis |
| 09/11/1998 | WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | WO1998039429A2 Compositions for treatment of disorders involving programmed cell death |
| 09/11/1998 | WO1998039427A2 Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters |
| 09/11/1998 | WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | WO1998039420A1 Filtration method for separating viruses |
| 09/11/1998 | WO1998039418A1 New applications of gene therapy technology |
| 09/11/1998 | WO1998039415A1 Established microglia |
| 09/11/1998 | WO1998039359A1 Dimeric cationic lipids on dicystine basis |
| 09/11/1998 | WO1998039352A1 Novel bicyclonucleoside and oligonucleotide analogues |
| 09/11/1998 | WO1998039035A1 Method and compositions for healing tissue defects and inducing hypervascularity in mammalian tissue |
| 09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/11/1998 | WO1998031712A3 Chitosan-conjugates with acidic chelate-complex forming agents |
| 09/11/1998 | WO1998030707A3 Eukaryotic gene expression cassette and uses thereof |
| 09/11/1998 | WO1998030692A3 Human endosulfine gene |
| 09/11/1998 | WO1998030687A3 Protein containing an srcr domain |
| 09/11/1998 | WO1998030585A3 Use of pea3 in tumor suppression |
| 09/11/1998 | WO1998025956A3 Human GTP-binding proteins |
| 09/11/1998 | CA2283394A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | CA2283241A1 Filtration method for separating viruses |
| 09/11/1998 | CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | CA2282708A1 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 09/11/1998 | CA2281915A1 Dimeric cationic lipids on dicystine basis |
| 09/11/1998 | CA2281484A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 09/10/1998 | DE19709512A1 Recombinant influenza virus |
| 09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0862644A2 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 09/09/1998 | EP0862643A1 Accessory functions for use in recombinant aav virion production |
| 09/09/1998 | EP0862642A1 Recombinant herpes virus vectors for expression in neuronal cells |
| 09/09/1998 | EP0862634A1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/09/1998 | EP0862633A1 Virus protein antigens of the jc virus |
| 09/09/1998 | EP0862629A1 Epithelial membrane protein-1 |
| 09/09/1998 | EP0862625A1 Methods for modulation of cholesterol transport |
| 09/09/1998 | EP0862619A1 Pskh-1 ribozymes and uses in disease treatment |
| 09/09/1998 | EP0862616A1 Reconstituted mineralized cartilage tissue |
| 09/09/1998 | EP0862615A1 Immunity against pasteurella haemolytica leukotoxin |
| 09/09/1998 | EP0862453A1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 09/09/1998 | EP0862445A1 Methods and compositions for viral enhancement of cell killing |
| 09/09/1998 | EP0862442A1 Methods for diagnosis and treatment of bloom's syndrome |
| 09/09/1998 | EP0862439A1 Ligands to enhance cellular uptake of biomolecules |
| 09/09/1998 | EP0862419A1 Microencapsulated dna for vaccination and gene therapy |
| 09/09/1998 | CN1192783A Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 09/09/1998 | CN1192781A Use of neuro-derived fetal cell lines for tranplantation therapy |
| 09/09/1998 | CN1192751A Monocype chemotactic protein-4 |
| 09/09/1998 | CN1192694A Vector for diagnosis and treatment of solid tumors including melanoma |
| 09/09/1998 | CN1192686A Method of treatment for lung diseases using antisense oligonucleotides |
| 09/09/1998 | CN1192473A Nucleic acid construct for expressing active substances which can be activated by proteases, and prepn. and use |
| 09/08/1998 | US5804683 Deprotection of RNA with alkylamine |
| 09/08/1998 | US5804566 Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides |
| 09/08/1998 | US5804431 Method, compositions and apparatus for cell transfection |
| 09/08/1998 | US5804383 Detecting expression of mutated or nonmutated human cystic fibrosis gene in tissue or cells |
| 09/08/1998 | US5804382 Hybridization of amplification-tagged tester dna and non-tagged driver dna in reaction mixture, removal of single-stranded dna and amplification tag prior to amplification of tester-tester homoduplex |
| 09/08/1998 | US5804376 Nucleotide and amino acid sequences; expression vector; genetically engineered host cells; diagnostic tests |
| 09/08/1998 | US5804191 Sperm as immunogen carriers |
| 09/05/1998 | CA2224108A1 Production of value-added milk by incorporation of specific dna sequences into mammary epithelial cells |
| 09/03/1998 | WO1998038325A2 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells |
| 09/03/1998 | WO1998038324A2 Chimeric cell-surface receptors that undergo antigen-induced association |
| 09/03/1998 | WO1998038317A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | WO1998038310A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | WO1998038305A1 Physiologically active protein originating in mammals |
| 09/03/1998 | WO1998038303A1 Procollagen assembly |
| 09/03/1998 | WO1998038204A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | WO1998038200A1 Nucleic acids encoding caspase-8h and caspase-8i |
| 09/03/1998 | WO1998037917A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | WO1998037916A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
| 09/03/1998 | WO1998037905A1 Arrestable therapeutic viral agent |
| 09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | WO1998037900A1 Use of the rna chosen instead of a protein in production of bioactive substances or for specific immunity control |
| 09/03/1998 | WO1998029566A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/03/1998 | WO1998022608A3 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 09/03/1998 | WO1998012327A3 Compositions and methods comprising bard1 and other brca1 binding proteins |
| 09/03/1998 | DE19808438A1 Retrovirale Vektoren, Verfahren zu ihrer Herstellung und ihre Verwendung zur Genübertragung in CD4-positive Zellen Retroviral vectors, processes for their preparation and their use for gene transfer into CD4-positive cells |
| 09/03/1998 | DE19716892C1 Vector for expressing immunoglobulin-cytokine fusion protein |
| 09/03/1998 | CA2283107A1 A tm4sf human tumor-associated antigen |
| 09/03/1998 | CA2282729A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | CA2282707A1 Factor x analogues with a modified protease cleavage site |
| 09/03/1998 | CA2282557A1 Physiologically active protein originating in mammals |
| 09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/03/1998 | CA2280690A1 Arrestable therapeutic viral agent |
| 09/03/1998 | CA2252942A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use |
| 09/03/1998 | CA2252790A1 Novel processes implementing selective immune down regulation (sidr) |
| 09/03/1998 | CA2252625A1 Chimeric cell-surface receptors that undergo antigen-induced association |
| 09/03/1998 | CA2198988A1 P28 bap31 a bcl-2 associated protein and use thereof for the modulation of apoptosis |
| 09/02/1998 | EP0861899A1 LicA polypeptides from Sreptococcus pneumoniae |